Exploring the interplay between tumor burden and liquid biopsy longitudinal evaluation in hormone receptor-positive, HER2-negative metastatic breast cancer (MBC)

被引：0
|
作者：
Mazzeo, R. [1 ]
Bortot, L. [1 ]
Michelotti, A. [1 ]
Buriolla, S. [1 ]
Palmero, L. [1 ]
Franzoni, A. [2 ]
Bertoli, E. [1 ]
Targato, G. [1 ]
Allegri, L. [2 ]
Da Ros, L. [3 ]
Alberti, M. [1 ]
Di Nardo, P. [3 ]
Bonotto, M. [4 ]
Sodde, S. [5 ]
Belletti, B. [6 ]
Spazzapan, S. [3 ]
Baldassarre, G. [6 ]
Damante, G. [2 ]
Gerratana, L. [1 ]
Puglisi, F. [3 ]
机构：
[1] Univ Udine, Dept Med DAME, Udine, Italy
[2] Azienda Sanit Univ Friuli Cent ASUFC Udine, Inst Human Genet, Udine, Italy
[3] Ctr Riferimento Oncol CRO IRCCS, Dept Med Oncol, Aviano, Italy
[4] Azienda Sanit Univ Friuli Cent ASUFC Udine, Med Oncol, Udine, Italy
[5] Ctr Riferimento Oncol CRO IRCCS, Clin Trial Off, Aviano, Italy
[6] Ctr Riferimento Oncol CRO IRCCS, Mol Oncol Unit, Aviano, Italy
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.576
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
293P
引用
收藏
页码：S492 / S493
页数：2
相关论文
共 50 条
  • [21] Effectiveness of platinum-based chemotherapy for hormone receptor-positive HER2-negative metastatic breast cancer
    Uratani, Lucas Fernando
    Bermejo, Francesco Sansone
    Hashizume, Pedro HenriqueShimiti
    Bonadio, Renata Colombo
    Testa, Laura
    CANCER RESEARCH, 2021, 81 (04)
  • [22] Plasma-Based Longitudinal Evaluation ofESR1Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer
    Gerratana, Lorenzo
    Basile, Debora
    Franzoni, Alessandra
    Allegri, Lorenzo
    Viotto, Davide
    Corvaja, Carla
    Bortot, Lucia
    Bertoli, Elisa
    Buriolla, Silvia
    Targato, Giada
    Da Ros, Lucia
    Russo, Stefania
    Bonotto, Marta
    Belletti, Barbara
    Baldassarre, Gustavo
    Damante, Giuseppe
    Puglisi, Fabio
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [23] Spatial interplay of lymphocytes and fibroblasts in estrogen receptor-positive HER2-negative breast cancer
    Nederlof, I
    Hajizadeh, S.
    Sobhani, F.
    Raza, S. E. A.
    AbdulJabbar, K.
    Harkes, R.
    van de Vijver, M. J.
    Salgado, R.
    Desmedt, C.
    Kok, M.
    Yuan, Y.
    Horlings, H. M.
    NPJ BREAST CANCER, 2022, 8 (01)
  • [24] Spatial interplay of lymphocytes and fibroblasts in estrogen receptor-positive HER2-negative breast cancer
    I. Nederlof
    S. Hajizadeh
    F. Sobhani
    S. E. A. Raza
    K. AbdulJabbar
    R. Harkes
    M. J. van de Vijver
    R. Salgado
    C. Desmedt
    M. Kok
    Y. Yuan
    H. M. Horlings
    npj Breast Cancer, 8
  • [25] Olaparib in hormone receptor-positive, HER2-negative metastatic breast cancer with a somatic BRCA2 mutation
    Schwartzberg, Lee S.
    Kiedrowski, Lesli A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [26] Migratory Tumor Cells Cooperate with Cancer Associated Fibroblasts in Hormone Receptor-Positive and HER2-Negative Breast Cancer
    Joo, Eun Hye
    Kim, Sangmin
    Park, Donghyun
    Lee, Taeseob
    Park, Woong-Yang
    Han, Kyung Yeon
    Lee, Jeong Eon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [27] The Evolving Use of SERDs in Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
    Jeselsohn, Rinath M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (07) : 428 - 431
  • [28] Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer
    Kahraman, Seda
    Erul, Enes
    Seyyar, Mustafa
    Gumusay, Ozge
    Bayram, Ertugrul
    Demirel, Burcin Cakan
    Acar, Omer
    Aksoy, Sercan
    Baytemur, Naziyet Kose
    Sahin, Elif
    Cabuk, Devrim
    Basaran, Gul
    Paydas, Semra
    Yaren, Arzu
    Guven, Deniz Can
    Erdogan, Atike Pinar
    Demirci, Umut
    Yasar, Alper
    Bayoglu, Ibrahim Vedat
    Hizal, Mutlu
    Gulbagci, Burcu
    Paksoy, Nail
    Davarci, Sena Ece
    Yilmaz, Funda
    Dogan, Ozlem
    Orhan, Sibel Oyucu
    Kayikcioglu, Erkan
    Aytac, Ali
    Keskinkilic, Merve
    Mocan, Eda Eylemer
    Unal, Olcun Umit
    Aydin, Esra
    Yucel, Hakan
    Isik, Deniz
    Eren, Onder
    Uluc, Basak Oyan
    Ozcelik, Melike
    Hacibekiroglu, Ilhan
    Aydiner, Adnan
    Demir, Hacer
    Oksuzoglu, Berna
    Cilbir, Ebru
    Cubukcu, Erdem
    Cetin, Bulent
    Oktay, Esin
    Erol, Cihan
    Okutur, Sadi Kerem
    Yildirim, Nilgun
    Alkan, Ali
    Selcukbiricik, Fatih
    FUTURE ONCOLOGY, 2023, : 727 - 736
  • [29] Fulvestrant and palbociclib combination in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer patients
    Hugo Herrscher
    Michel Velten
    Julie Leblanc
    Michal Kalish-Weindling
    Cathie Fischbach
    Delphine Exinger
    Xavier Pivot
    Thierry Petit
    Breast Cancer Research and Treatment, 2020, 179 : 371 - 376
  • [30] The clinical impact of NOLUS in unresectable/metastatic hormone receptor-positive (HR+)/HER2-negative breast cancer
    Tajiri, Wakako
    Nakamura, Yoshiaki
    Kawasaki, Junji
    Koi, Yumiko
    Akiyoshi, Sayuri
    Koga, Chinami
    Tokunaga, Eriko
    CANCER RESEARCH, 2024, 84 (09)
12345